Milliken & Company Charitable Foundation Expands Associate Gift Match Program
"Making a substantial positive impact is an essential part of Milliken's mission and purpose," said
The original gift match program focused on providing support for public and private universities and private elementary, middle, and high schools. Now, the Milliken & Company Charitable Foundation will match every dollar an associate donates up to
"At Milliken, we've always cared about the communities where we live and work — and we act with intention to demonstrate this care," said
Milliken has a long-standing commitment to community engagement. Building on that legacy, the company formally established the reconstituted Milliken & Company Charitable Foundation in
To learn more about the Milliken & Company Charitable Foundation, visit milliken.com/foundation.
About Milliken
Milliken & Company is a global manufacturing leader whose focus on materials science delivers tomorrow's breakthroughs today. From industry-leading molecules to sustainable innovations, Milliken creates products that enhance people's lives and deliver solutions for its customers and communities. Drawing on thousands of patents and a portfolio with applications across the textile, flooring, chemical and healthcare businesses, the company harnesses a shared sense of integrity and excellence to positively impact the world for generations. Discover more about Milliken's curious minds and inspired solutions at milliken.com and on Facebook, Instagram, LinkedIn and Twitter.
View original content to download multimedia:https://www.prnewswire.com/news-releases/milliken--company-charitable-foundation-expands-associate-gift-match-program-302111665.html
SOURCE Milliken & Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Segway's 2026 World Cup Ride Campaign Highlights Strong User Adoption of Shared Micromobility
- Voluntary Recall of Two Lots of PEDIGREE® Can High Protein Chopped Chicken & Duck Flavor Wet Dog Food Due to Potential Fraudulent Distribution of Product Which May Contain Foreign Material
- Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share